Pharma stocks in which ICICI Group bought fresh stake of up to 4 percent in Q2 - Trade Brains
| AMRUTANJAN | 737.95 10.65 1.46% |
About 51% of Amrutanjan Health's investors are presently thinking to get in. The analysis of overall sentiment of trading Amrutanjan Health Care stock suggests that some investors are interested at this time. Amrutanjan Health's investing sentiment overview a quick insight into current market opportunities from investing in Amrutanjan Health Care. Many technical investors use Amrutanjan Health Care stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Amrutanjan |
Pharma stocks in which ICICI Group bought fresh stake of up to 4 percent in Q2 Trade Brains
Read at news.google.com
 |
Amrutanjan Health Fundamental Analysis
We analyze Amrutanjan Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amrutanjan Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amrutanjan Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Amrutanjan Health is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Amrutanjan Health Care Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amrutanjan Health stock to make a market-neutral strategy. Peer analysis of Amrutanjan Health could also be used in its relative valuation, which is a method of valuing Amrutanjan Health by comparing valuation metrics with similar companies.
Peers
Amrutanjan Health Related Equities
| MRF | MRF | 1.28 | ||||
| ABBOTINDIA | Abbott India | 1.26 | ||||
| BOSCHLTD | Bosch | 0.84 | ||||
| BAJAJHLDNG | Bajaj Holdings | 0.75 | ||||
| VHL | Vardhman Holdings | 0.38 |
Other Information on Investing in Amrutanjan Stock
Amrutanjan Health financial ratios help investors to determine whether Amrutanjan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amrutanjan with respect to the benefits of owning Amrutanjan Health security.